share_log

TT BioPharm Has Received A Decision To Grant European Patent Number EP3283620 Titled "Modified Gamma Delta Cells And Uses Thereof (For The Treatment Of Cancer Or Infectious Diseases In A Human)"

TT BioPharm Has Received A Decision To Grant European Patent Number EP3283620 Titled "Modified Gamma Delta Cells And Uses Thereof (For The Treatment Of Cancer Or Infectious Diseases In A Human)"

TT BioPharm 已收到一項授予歐洲專利號 EP3283620 的決定，該專利號爲 “改性伽瑪三角洲細胞及其用途（用於治療人類癌症或傳染病）”
Benzinga ·  03/22 03:32

EP About this file - European Patent Register (epo.org)

EP 關於此文件-歐洲專利註冊局 (epo.org)

Image

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論